Locally advanced breast cancer: Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy

René Gilles, Jean Marc Guinebretière, Caroline Toussaint, Marc Spielman, Mario Rietjens, Jean Yves Petit, Geneviève Contesso, Jacques Masselot, Daniel Vanel

Research output: Contribution to journalArticle

203 Citations (Scopus)

Abstract

PURPOSE: To determine the value of contrast material-enhanced subtraction magnetic resonance (MR) imaging in assessment of response to chemotherapy in locally advanced breast cancer. MATERIALS AND METHODS: Eighteen women treated with chemotherapy because of locally advanced breast cancer underwent preoperative MR examination including both routine and dynamic MR sequences after injection of gadolinium tetraazacyclododecanetetraacetic acid. Any early contrast enhancement, concomitant with early vascular enhancement during the dynamic MR study, was considered pathologic. RESULTS: Dynamic MR studies showed early contrast enhancement in all women with residual tumor except one with nodular residual tumor. Histopathologic analysis and dynamic MR images of contrast-enhanced lesions correlated well, but in one patient, intraductal extension was not seen on MR images, and in another, additional isolated tumor cells were seen in the histologic specimen. Subtraction images always facilitated visualization of vascular and pathologic contrast enhancement. CONCLUSION: Dynamic MR contrast-enhanced subtraction studies are useful in assessment of residual tumor after chemotherapy.

Original languageEnglish
Pages (from-to)633-638
Number of pages6
JournalRadiology
Volume191
Issue number3
Publication statusPublished - Jun 1994

Fingerprint

Magnetic Resonance Spectroscopy
Magnetic Resonance Imaging
Breast Neoplasms
Drug Therapy
Residual Neoplasm
Blood Vessels
Gadolinium
Contrast Media
Injections
Acids
Neoplasms

Keywords

  • Breast neoplasms, diagnosis
  • Breast neoplasms, therapy
  • Breast, MR
  • Magnetic resonance (MR), contrast enhancement

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Gilles, R., Guinebretière, J. M., Toussaint, C., Spielman, M., Rietjens, M., Petit, J. Y., ... Vanel, D. (1994). Locally advanced breast cancer: Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology, 191(3), 633-638.

Locally advanced breast cancer : Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. / Gilles, René; Guinebretière, Jean Marc; Toussaint, Caroline; Spielman, Marc; Rietjens, Mario; Petit, Jean Yves; Contesso, Geneviève; Masselot, Jacques; Vanel, Daniel.

In: Radiology, Vol. 191, No. 3, 06.1994, p. 633-638.

Research output: Contribution to journalArticle

Gilles, R, Guinebretière, JM, Toussaint, C, Spielman, M, Rietjens, M, Petit, JY, Contesso, G, Masselot, J & Vanel, D 1994, 'Locally advanced breast cancer: Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy', Radiology, vol. 191, no. 3, pp. 633-638.
Gilles, René ; Guinebretière, Jean Marc ; Toussaint, Caroline ; Spielman, Marc ; Rietjens, Mario ; Petit, Jean Yves ; Contesso, Geneviève ; Masselot, Jacques ; Vanel, Daniel. / Locally advanced breast cancer : Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. In: Radiology. 1994 ; Vol. 191, No. 3. pp. 633-638.
@article{0eed112eb3464c6b87d6663747dd6f02,
title = "Locally advanced breast cancer: Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy",
abstract = "PURPOSE: To determine the value of contrast material-enhanced subtraction magnetic resonance (MR) imaging in assessment of response to chemotherapy in locally advanced breast cancer. MATERIALS AND METHODS: Eighteen women treated with chemotherapy because of locally advanced breast cancer underwent preoperative MR examination including both routine and dynamic MR sequences after injection of gadolinium tetraazacyclododecanetetraacetic acid. Any early contrast enhancement, concomitant with early vascular enhancement during the dynamic MR study, was considered pathologic. RESULTS: Dynamic MR studies showed early contrast enhancement in all women with residual tumor except one with nodular residual tumor. Histopathologic analysis and dynamic MR images of contrast-enhanced lesions correlated well, but in one patient, intraductal extension was not seen on MR images, and in another, additional isolated tumor cells were seen in the histologic specimen. Subtraction images always facilitated visualization of vascular and pathologic contrast enhancement. CONCLUSION: Dynamic MR contrast-enhanced subtraction studies are useful in assessment of residual tumor after chemotherapy.",
keywords = "Breast neoplasms, diagnosis, Breast neoplasms, therapy, Breast, MR, Magnetic resonance (MR), contrast enhancement",
author = "Ren{\'e} Gilles and Guinebreti{\`e}re, {Jean Marc} and Caroline Toussaint and Marc Spielman and Mario Rietjens and Petit, {Jean Yves} and Genevi{\`e}ve Contesso and Jacques Masselot and Daniel Vanel",
year = "1994",
month = "6",
language = "English",
volume = "191",
pages = "633--638",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "3",

}

TY - JOUR

T1 - Locally advanced breast cancer

T2 - Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy

AU - Gilles, René

AU - Guinebretière, Jean Marc

AU - Toussaint, Caroline

AU - Spielman, Marc

AU - Rietjens, Mario

AU - Petit, Jean Yves

AU - Contesso, Geneviève

AU - Masselot, Jacques

AU - Vanel, Daniel

PY - 1994/6

Y1 - 1994/6

N2 - PURPOSE: To determine the value of contrast material-enhanced subtraction magnetic resonance (MR) imaging in assessment of response to chemotherapy in locally advanced breast cancer. MATERIALS AND METHODS: Eighteen women treated with chemotherapy because of locally advanced breast cancer underwent preoperative MR examination including both routine and dynamic MR sequences after injection of gadolinium tetraazacyclododecanetetraacetic acid. Any early contrast enhancement, concomitant with early vascular enhancement during the dynamic MR study, was considered pathologic. RESULTS: Dynamic MR studies showed early contrast enhancement in all women with residual tumor except one with nodular residual tumor. Histopathologic analysis and dynamic MR images of contrast-enhanced lesions correlated well, but in one patient, intraductal extension was not seen on MR images, and in another, additional isolated tumor cells were seen in the histologic specimen. Subtraction images always facilitated visualization of vascular and pathologic contrast enhancement. CONCLUSION: Dynamic MR contrast-enhanced subtraction studies are useful in assessment of residual tumor after chemotherapy.

AB - PURPOSE: To determine the value of contrast material-enhanced subtraction magnetic resonance (MR) imaging in assessment of response to chemotherapy in locally advanced breast cancer. MATERIALS AND METHODS: Eighteen women treated with chemotherapy because of locally advanced breast cancer underwent preoperative MR examination including both routine and dynamic MR sequences after injection of gadolinium tetraazacyclododecanetetraacetic acid. Any early contrast enhancement, concomitant with early vascular enhancement during the dynamic MR study, was considered pathologic. RESULTS: Dynamic MR studies showed early contrast enhancement in all women with residual tumor except one with nodular residual tumor. Histopathologic analysis and dynamic MR images of contrast-enhanced lesions correlated well, but in one patient, intraductal extension was not seen on MR images, and in another, additional isolated tumor cells were seen in the histologic specimen. Subtraction images always facilitated visualization of vascular and pathologic contrast enhancement. CONCLUSION: Dynamic MR contrast-enhanced subtraction studies are useful in assessment of residual tumor after chemotherapy.

KW - Breast neoplasms, diagnosis

KW - Breast neoplasms, therapy

KW - Breast, MR

KW - Magnetic resonance (MR), contrast enhancement

UR - http://www.scopus.com/inward/record.url?scp=0028290695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028290695&partnerID=8YFLogxK

M3 - Article

C2 - 8184039

AN - SCOPUS:0028290695

VL - 191

SP - 633

EP - 638

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 3

ER -